ETDD Conferences

Developer: OpenConcept Systems, Inc.

Category: Business

221 installs

ratings

ASO Keyword Dashboard

Tracking 64 keywords for ETDD Conferences in Google Play

Developer: OpenConcept Systems, Inc. Category: business

ETDD Conferences tracks 64 keywords (no keywords rank yet; 64 need traction). Key metrics: opportunity 69.7, difficulty 45.9.

The official conference app for Epilepsy Therapies & Diagnostic Developments.

Tracked keywords

0 ranked • 64 not ranking yet

Top 10 coverage

—

Best rank — • Latest leader —

Avg opportunity

69.7

Top keyword: excellent

Avg difficulty

45.9

Lower scores indicate easier wins

Opportunity leaders

excellent

Opportunity: 73.0 • Difficulty: 47.1 • Rank —

Competitors: 1,176
68.7
complex

Opportunity: 72.0 • Difficulty: 51.2 • Rank —

Competitors: 1,186
69.8
strategies

Opportunity: 72.0 • Difficulty: 44.5 • Rank —

Competitors: 708
64.0
past

Opportunity: 72.0 • Difficulty: 48.6 • Rank —

Competitors: 1,108
70.0
issues

Opportunity: 72.0 • Difficulty: 47.5 • Rank —

Competitors: 859
68.8

Unranked opportunities

excellent

Opportunity: 73.0 • Difficulty: 47.1 • Competitors: 1,176
complex

Opportunity: 72.0 • Difficulty: 51.2 • Competitors: 1,186
strategies

Opportunity: 72.0 • Difficulty: 44.5 • Competitors: 708
past

Opportunity: 72.0 • Difficulty: 48.6 • Competitors: 1,108
issues

Opportunity: 72.0 • Difficulty: 47.5 • Competitors: 859

High competition keywords

new

Total apps: 193,474 • Major competitors: 25,823

Latest rank: — • Difficulty: 65.7
many

Total apps: 96,753 • Major competitors: 12,574

Latest rank: — • Difficulty: 61.9
data

Total apps: 68,455 • Major competitors: 6,589

Latest rank: — • Difficulty: 65.4
always

Total apps: 65,220 • Major competitors: 7,264

Latest rank: — • Difficulty: 58.5
learn

Total apps: 64,313 • Major competitors: 6,746

Latest rank: — • Difficulty: 60.5

All tracked keywords

Includes opportunity, difficulty, rankings and competitor benchmarks

							Major Competitors
new	64	100	66	90 193,474 competing apps Median installs: 42,470 Avg rating: 3.0	—	—	25,823 major competitor apps
focus	71	100	59	73 18,611 competing apps Median installs: 23,658 Avg rating: 2.9	—	—	1,710 major competitor apps
device	68	100	72	81 52,389 competing apps Median installs: 37,519 Avg rating: 3.0	—	—	6,390 major competitor apps
learn	67	100	61	82 64,313 competing apps Median installs: 33,093 Avg rating: 2.8	—	—	6,746 major competitor apps
enhance	69	100	55	77 30,373 competing apps Median installs: 33,880 Avg rating: 3.0	—	—	3,622 major competitor apps
excellent	73	100	47	69 10,547 competing apps Median installs: 34,859 Avg rating: 2.8	—	—	1,176 major competitor apps
exciting	68	100	58	79 44,810 competing apps Median installs: 50,380 Avg rating: 3.0	—	—	7,403 major competitor apps
move	70	100	59	75 25,275 competing apps Median installs: 43,577 Avg rating: 3.1	—	—	3,641 major competitor apps
diagnostic	70	100	53	55 1,622 competing apps Median installs: 19,557 Avg rating: 2.6	—	—	105 major competitor apps
diagnostics	69	100	41	47 575 competing apps Median installs: 22,175 Avg rating: 2.6	—	—	58 major competitor apps
related	70	100	51	75 24,302 competing apps Median installs: 26,107 Avg rating: 2.5	—	—	1,820 major competitor apps
many	66	100	62	85 96,753 competing apps Median installs: 43,740 Avg rating: 2.9	—	—	12,574 major competitor apps
bring	69	100	60	77 32,601 competing apps Median installs: 42,726 Avg rating: 3.0	—	—	4,623 major competitor apps
face	70	100	55	75 24,650 competing apps Median installs: 46,450 Avg rating: 3.1	—	—	3,493 major competitor apps
together	71	100	55	74 20,460 competing apps Median installs: 38,864 Avg rating: 2.9	—	—	2,694 major competitor apps
always	67	100	59	82 65,220 competing apps Median installs: 32,990 Avg rating: 2.9	—	—	7,264 major competitor apps
official	69	100	60	78 38,012 competing apps Median installs: 28,214 Avg rating: 2.7	—	—	3,398 major competitor apps
devices	70	100	67	75 25,598 competing apps Median installs: 36,807 Avg rating: 3.0	—	—	3,146 major competitor apps
personalized	70	100	60	76 28,852 competing apps Median installs: 31,583 Avg rating: 3.0	—	—	3,359 major competitor apps
progress	70	100	54	76 27,030 competing apps Median installs: 29,906 Avg rating: 3.1	—	—	2,895 major competitor apps
increased	71	100	39	58 2,480 competing apps Median installs: 29,604 Avg rating: 2.9	—	—	247 major competitor apps
data	67	100	65	83 68,455 competing apps Median installs: 26,834 Avg rating: 2.7	—	—	6,589 major competitor apps
era	71	100	41	61 3,545 competing apps Median installs: 38,096 Avg rating: 2.8	—	—	446 major competitor apps
ensure	70	100	59	76 27,894 competing apps Median installs: 27,644 Avg rating: 2.8	—	—	2,884 major competitor apps
conference	70	100	35	54 1,480 competing apps Median installs: 16,646 Avg rating: 2.7	—	—	108 major competitor apps

App Description

The official conference app for Epilepsy Therapies & Diagnostic Developments.

This is the seventeenth conference focusing on issues related to Epilepsy Therapies & Diagnostic Developments (ETDD) from preclinical discoveries through clinical evaluations. We are fortunate to have a robust epilepsy drug and device pipeline, fueled by excellent science and novel ideas. We are entering an exciting era where therapies targeted at disease modification , rather than just anti-seizure treatment are emerging, and there is a focus on personalized treatments. There are also many treatments in the pipeline for orphan diseases. There is a burgeoning pipeline of wearable and implantable diagnostic devices. New therapeutic devices are also under development. New innovations in therapy and diagnostics may face roadblocks such as complex regulatory requirements, increased payer expectations, and issues in data quality, but progress has been made. At each ETDD conference, we re-evaluate strategies to ensure continued advancement. There is always the opportunity to learn from the past as we move into the future. This symposium will bring together representatives from academia, industry, and the NIH, to review what has been learned and to discuss strategies to enhance epilepsy therapy and diagnostics development.